After Pass'Aje: Psychiatric Future of Young Patients Hospitalized in the Pass'Aje Service Between 2006 and 2010

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Unknown status
CT.gov ID
NCT03309670
Collaborator
(none)
660
1
20
33

Study Details

Study Description

Brief Summary

The emergence of adult psychic disorders occurs in about three quarters of cases before 25 years. The Pass-Aje service of Clermont-Ferrand University Hospital is a psychiatric unit specializing in the management of disorders of young adults. This unit evaluates the first episodes among the diversity of the clinical presentations of the psychic disorders. Suicidal attempts or ideations account for a large part of the reasons for entering the unit and are found transversely in many disorders. Among the reasons for hospitalization are a wide variety of situations that are not initially associated with an accurate diagnosis such as withdrawal, de-schooling, runaways, behavioral disorders (disorders of social interactions, self and hetero aggression, eating disorders).

Investigator propose to study the psychiatric outcome of hospitalized patients in the Pass-Aje unit and their psychosocial evolution in order to compare them with the data of the general population and to identify the factors influencing their future.

Condition or Disease Intervention/Treatment Phase
  • Other: Psychiatric future

Detailed Description

Former young psychiatric patients hospitalized in the Pass'Aje units are contacted by phone several years later to determine their psychiatric outcome.

Study Design

Study Type:
Observational
Anticipated Enrollment :
660 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Psychiatric Future of Young Patients Hospitalized in the Pass'Aje Service Between 2006 and 2010
Actual Study Start Date :
Sep 14, 2017
Actual Primary Completion Date :
Sep 15, 2017
Anticipated Study Completion Date :
May 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Formers young patients

all patients hospitalized between 2006 and 2010 in the Pass'Aje unit

Other: Psychiatric future
Former young psychiatric patients are contacted to determine their psychiatric outcome.

Outcome Measures

Primary Outcome Measures

  1. Psychiatric rehospitalisation [at day 1 during the phone call]

    the psychiatric outcome comprises 3 parameters : ongoing psychiatric follow-up (yes / no) psychotropic treatment in progress (yes / no) psychiatric hospitalizations after the first hospitalization in Pass'Aje (yes / no)

Secondary Outcome Measures

  1. Determination of social outcomes [at day 1 during the phone call]

    Educational level of obtained by patients will be compared to data of the general population according to sex, age and parents' social environment

  2. Percentage of patients with an occupational activity [at day 1 during the phone call]

    Percentage of patients with an occupational activity will be compared to data of the general population according to sex, age and parents' social environment

Eligibility Criteria

Criteria

Ages Eligible for Study:
23 Years to 36 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all patients hospitalized in the Pass'Aje unit between 2006 and 2010

  • Aged from 16 to 25 years when hospitalized

Exclusion Criteria:
  • Patient refusing or not understanding the purpose of the study.

  • Patients who died.

  • Patient phone number unavailable or non-functional

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Clermont-Ferrand Clermont-Ferrand France 63003

Sponsors and Collaborators

  • University Hospital, Clermont-Ferrand

Investigators

  • Principal Investigator: Eve COURTY, University Hospital, Clermont-Ferrand

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT03309670
Other Study ID Numbers:
  • CHU-355
First Posted:
Oct 13, 2017
Last Update Posted:
Feb 4, 2019
Last Verified:
Feb 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Clermont-Ferrand

Study Results

No Results Posted as of Feb 4, 2019